ISTH_2017 - Sponsorship Prospectus

4-5 / 69

Exhibition and Sponsorship Sales Prospectus
July 8 - 13, 2017 | Berlin, Germany ISTH 2017 | Transcending Scientific Boundaries
4 5
CONFERENCE COMMITTEES WELCOME MESSAGE
Welcome Message
Thank you for your interest in the XXVI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
and 63rd Annual Meeting of the Scientific and Standardization Committee (SSC).
ISTH congresses are the premier scientific events in the field of thrombosis, hemostasis and wider benign hematology
and address the immediate and future scientific, laboratory and clinical opportunities and challenge.
ISTH meetings accomplish this by bringing together thousands of experienced, thought-leading clinicians and resear-
chers as well as young scientists from around the globe who present their latest discoveries in their quest and commit-
ment to advance the scientific understanding and translate scientific knowledge into new approaches to diagnosis and
treatment of thrombotic and bleeding disorders.
Apart from an outstanding scientific and educational program that will foster this sharing of knowledge and advancing
scientific discoveries, critically important for our attendees - and ultimately the patients - are the diagnostics and
treatments that laboratory scientists and clinicians have at their disposal today or are in development.
We are therefore committed to giving the collaboration with our industry partners highest importance.
Through your presence at ISTH 2017, you will have the opportunity to connect with an expected 8,000 leading experts,
many of whom are clinicians, clinical investigators in trials, key opinion leaders, educators and leading laboratory
scientists from around the world who are dedicated to resolving clinical and laboratory challenges, developing new
therapeutic approaches and improving the care of patients.
Your participation allows you to be part of essential discussions, directly interact with thought and opinion leaders
from around the world, obtain insights into cutting edge developments, educate about and promote your products and
services, and showcase your own scientific and therapeutic advancements and commitment to supporting the evolution
of science and education in our field.
This is the most exciting time to be involved and we look forward to your partnership and support of one of the most
important medical and scientific events in our field!
We look forward to welcoming you to ISTH 2017 in Berlin.
Scientific Leadership & Main Topics
ISTH 2017 ORGANIZING COMMITTEE
President Johannes Oldenburg Bonn, Germany
Vice-President Ingrid Pabinger Vienna, Austria
Scientific Program Co-Chair Anne Angelillo-Scherrer Bern, Switzerland
Scientific Program Co-Chair Christian Weber Munich, Germany
Educational Program Chair/SSC Liaison Andreas Greinacher Greifswald, Germany
Clinical Program Chair Christine Mannhalter Vienna, Austria
Basic Science Program Chair Klaus T. Preissner Giessen, Germany
GTH Liaison Bettina Kemkes-Matthes Giessen, Germany
Guest Editor, State of the Art Reviews Wolfram Ruf Mainz, Germany
Pediatric Topics Liaison Christoph Male Vienna, Austria
SCIENTIFIC PROGRAM COMMITTEE CHAIRS
Atherothrombosis & Stroke Christoph Binder Vienna, Austria
Coagulant & Anticoagulant Mechanisms Berend Isermann Magdeburg, Germany
Coagulation Signaling & Immunity Bernd Engelmann Munich, Germany
Diagnostics and OMICs Karl Lackner Mainz, Germany
Fibrinolysis & Proteolysis Johann Wojta Vienna, Austria
Hemorrhagic Disorders, Hemophilia Andreas Tiede Hannover, Germany
Management of Thromboembolism Stavros Konstantinides Mainz, Germany
Nurses Program Kate Kahir London, UK
Pathogenesis of Thromboembolism Sabine Eichinger Vienna, Austria
Platelets – Basic Bernhard Nieswandt Wurzburg, Germany
Platelets – Clinical Meinrad Gawaz Tuebingen, Germany
Transfusion & Biotherapeutics Erhard Seifried Frankfurt, Germany
Vascular Biology & Angiogenesis Hellmut Augustin Heidelberg, Germany